{"id":8964,"date":"2018-04-11T15:45:03","date_gmt":"2018-04-11T15:45:03","guid":{"rendered":"http:\/\/fefac.cat\/empresarial\/?p=8964"},"modified":"2018-04-11T15:45:03","modified_gmt":"2018-04-11T15:45:03","slug":"la-cooperaci-entre-investigadors-administraci-i","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/la-cooperaci-entre-investigadors-administraci-i\/","title":{"rendered":"La cooperaci\u00f3 entre investigadors, Administraci\u00f3 i empreses \u00e9s clau per trobar nous antibi\u00f2tics"},"content":{"rendered":"<p><strong>L&rsquo;ag&egrave;ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS)<\/strong> va acollir el 10 d&rsquo;abril la 1&ordf; Jornada de l&rsquo;Associaci&oacute; per al Descobriment de Nous Antibi&ograve;tics a Espanya (AD-ES), amb experts nacionals i internacionals per abordar la <strong>resist&egrave;ncia als antibi&ograve;tics.<\/strong><\/p>\n<p>La resist&egrave;ncia als antibi&ograve;tics provoca cada any a Europa<strong> 25.000 morts (2.800 a Espanya)<\/strong>, i infeccions greus a m&eacute;s de quatre milions de persones. Aquestes xifres converteixen la recerca i la investigaci&oacute; de nous antibi&ograve;tics i antibacterians en un problema de salut p&uacute;blica. Es calcula que les infeccions podrien provocar la mort de <strong>10 milions de persones <\/strong>l&rsquo;any 2050 si no es troben nous tractaments, convertint-se en la <strong>primera causa de mort<\/strong> del planeta.<\/p>\n<p>La directora de l&rsquo;AEMPS, <strong>Bel&eacute;n Crespo<\/strong>, ha subratllat la import&agrave;ncia de la <strong>cooperaci&oacute; <\/strong>per al desenvolupament de nous antibi&ograve;tics. <em>&ldquo;La col&middot;laboraci&oacute; compartint experi&egrave;ncies i coneixements &eacute;s una de les raons de l&rsquo;&egrave;xit del Pla Nacional enfront de la Resist&egrave;ncia als Antibi&ograve;tics (PRAN) i ha de ser tamb&eacute; l&rsquo;eix de la R+D a l&rsquo;&agrave;rea de noves ter&agrave;pies antimicrobianes&rdquo;<\/em>, ha assenyalat.<\/p>\n<p><strong>C&eacute;sar Hern&aacute;ndez<\/strong>, cap del Departament de Medicaments d&rsquo;&Uacute;s Hum&agrave; de l&rsquo;AEMPS, ha destacat el paper que poden exercir les <strong>ag&egrave;ncies reguladores<\/strong> per ajudar al desenvolupament de nous i millors antibi&ograve;tics, explicant la tasca de l&rsquo;Oficina de Suport a la Innovaci&oacute; i Coneixement sobre Medicaments de l&rsquo;AEMPS, integrada a la UE-InnovationNetwork, de la qual forma part l&rsquo;EMA i altres 23 oficines d&rsquo;innovaci&oacute; europees, que presta assessoria cient&iacute;fica i reguladora a grups de recerca.<\/p>\n<p><em>&ldquo;La recerca de nous medicaments ha d&rsquo;estar orientada des del principi al fet que aquests medicaments acabin arribant i beneficiant als pacients. El desenvolupament d&rsquo;un medicament pot fracassar quan la hip&ograve;tesi inicial &eacute;s equivocada, per&ograve; cal evitar que fracassi perqu&egrave; el programa de desenvolupament no &eacute;s l&rsquo;adequat o perqu&egrave; s&rsquo;han planificat estudis mal dissenyats&rdquo;<\/em>, ha concretat C&eacute;sar Hern&aacute;ndez.<\/p>\n<p><strong>Domingo Gargallo-Viola<\/strong>, president de l&rsquo;Associaci&oacute; per al Descobriment de nous antibi&ograve;tics a Espanya <strong>(AD-ES)<\/strong>, ha ressaltat el paper d&rsquo;aquesta entitat cient&iacute;fica sense &agrave;nim de lucre en la promoci&oacute; de la recerca per combatre el fenomen de la resist&egrave;ncia antimicrobiana.<em> &ldquo;Jornades com aquesta tracten de fomentar la formaci&oacute; dels professionals i impulsar la recerca en aquest camp, afavorint la comunicaci&oacute; entre l&rsquo;administraci&oacute;, la ind&uacute;stria, la comunitat cient&iacute;fica i la societat&rdquo;<\/em>, ha dit.<\/p>\n<p><strong>L&rsquo;&uacute;s inadequat i indiscriminat<\/strong> dels mateixos &eacute;s un dels factors principals que contribueixen a aquest fenomen, juntament amb el control deficient de la infecci&oacute; bacteriana. Tamb&eacute; va assistir<strong> Jeremy Knox<\/strong>, del grup d&rsquo;infeccions resistents del Wellcome Trust (Regne Unit); i <strong>Richard Bax<\/strong>, de la companyia brit&agrave;nica TranScript.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L&rsquo;ag&egrave;ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS) va acollir el 10 d&rsquo;abril la 1&ordf; Jornada de l&rsquo;Associaci&oacute; per al Descobriment de Nous Antibi&ograve;tics a Espanya (AD-ES), amb experts nacionals [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[18,11,12,13,14,15,101],"tags":[55,188,357],"class_list":["post-8964","post","type-post","status-publish","format-standard","hentry","category-general","category-fefac","category-afb","category-afet","category-afell","category-agfe","category-sanitaria","tag-antibiotics","tag-aemps","tag-sanitat"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La cooperaci\u00f3 entre investigadors, Administraci\u00f3 i empreses \u00e9s clau per trobar nous antibi\u00f2tics - FEFAC<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/la-cooperaci-entre-investigadors-administraci-i\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La cooperaci\u00f3 entre investigadors, Administraci\u00f3 i empreses \u00e9s clau per trobar nous antibi\u00f2tics - FEFAC\" \/>\n<meta property=\"og:description\" content=\"L&rsquo;ag&egrave;ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS) va acollir el 10 d&rsquo;abril la 1&ordf; Jornada de l&rsquo;Associaci&oacute; per al Descobriment de Nous Antibi&ograve;tics a Espanya (AD-ES), amb experts nacionals [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/la-cooperaci-entre-investigadors-administraci-i\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2018-04-11T15:45:03+00:00\" \/>\n<meta name=\"author\" content=\"qabh859\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"qabh859\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-cooperaci-entre-investigadors-administraci-i\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-cooperaci-entre-investigadors-administraci-i\\\/\"},\"author\":{\"name\":\"qabh859\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\"},\"headline\":\"La cooperaci\u00f3 entre investigadors, Administraci\u00f3 i empreses \u00e9s clau per trobar nous antibi\u00f2tics\",\"datePublished\":\"2018-04-11T15:45:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-cooperaci-entre-investigadors-administraci-i\\\/\"},\"wordCount\":569,\"keywords\":[\"antibi\u00f2tics\",\"AEMPS\",\"sanitat\"],\"articleSection\":[\"General\",\"FEFAC\",\"AFB\",\"AFET\",\"AFELL\",\"AGFE\",\"Sanit\u00e0ria\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-cooperaci-entre-investigadors-administraci-i\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-cooperaci-entre-investigadors-administraci-i\\\/\",\"name\":\"La cooperaci\u00f3 entre investigadors, Administraci\u00f3 i empreses \u00e9s clau per trobar nous antibi\u00f2tics - FEFAC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"datePublished\":\"2018-04-11T15:45:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-cooperaci-entre-investigadors-administraci-i\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-cooperaci-entre-investigadors-administraci-i\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-cooperaci-entre-investigadors-administraci-i\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La cooperaci\u00f3 entre investigadors, Administraci\u00f3 i empreses \u00e9s clau per trobar nous antibi\u00f2tics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\",\"name\":\"qabh859\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/qabh859\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La cooperaci\u00f3 entre investigadors, Administraci\u00f3 i empreses \u00e9s clau per trobar nous antibi\u00f2tics - FEFAC","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/la-cooperaci-entre-investigadors-administraci-i\/","og_locale":"ca_ES","og_type":"article","og_title":"La cooperaci\u00f3 entre investigadors, Administraci\u00f3 i empreses \u00e9s clau per trobar nous antibi\u00f2tics - FEFAC","og_description":"L&rsquo;ag&egrave;ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS) va acollir el 10 d&rsquo;abril la 1&ordf; Jornada de l&rsquo;Associaci&oacute; per al Descobriment de Nous Antibi&ograve;tics a Espanya (AD-ES), amb experts nacionals [&hellip;]","og_url":"https:\/\/fefac.cat\/empresarial\/la-cooperaci-entre-investigadors-administraci-i\/","og_site_name":"FEFAC","article_published_time":"2018-04-11T15:45:03+00:00","author":"qabh859","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"qabh859","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/la-cooperaci-entre-investigadors-administraci-i\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/la-cooperaci-entre-investigadors-administraci-i\/"},"author":{"name":"qabh859","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7"},"headline":"La cooperaci\u00f3 entre investigadors, Administraci\u00f3 i empreses \u00e9s clau per trobar nous antibi\u00f2tics","datePublished":"2018-04-11T15:45:03+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/la-cooperaci-entre-investigadors-administraci-i\/"},"wordCount":569,"keywords":["antibi\u00f2tics","AEMPS","sanitat"],"articleSection":["General","FEFAC","AFB","AFET","AFELL","AGFE","Sanit\u00e0ria"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/la-cooperaci-entre-investigadors-administraci-i\/","url":"https:\/\/fefac.cat\/empresarial\/la-cooperaci-entre-investigadors-administraci-i\/","name":"La cooperaci\u00f3 entre investigadors, Administraci\u00f3 i empreses \u00e9s clau per trobar nous antibi\u00f2tics - FEFAC","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"datePublished":"2018-04-11T15:45:03+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7"},"breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/la-cooperaci-entre-investigadors-administraci-i\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/la-cooperaci-entre-investigadors-administraci-i\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/la-cooperaci-entre-investigadors-administraci-i\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"La cooperaci\u00f3 entre investigadors, Administraci\u00f3 i empreses \u00e9s clau per trobar nous antibi\u00f2tics"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7","name":"qabh859","url":"https:\/\/fefac.cat\/empresarial\/author\/qabh859\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/8964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=8964"}],"version-history":[{"count":0,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/8964\/revisions"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=8964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=8964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=8964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}